This global technical consultation report brings together viewpoints from experts spanning a range of disciplines with the key objective of seeking consensus regarding the terminology used to describe the transmission of pathogens through the air that can potentially cause infection in humans.
This guidance outlines key strategic and operational considerations to inform pandemic preparedness planning round the design and implementation of public health and social measures in community settings in the EU/EEA.
In 2022, 1 149 confirmed cases of invasive meningococcal disease (IMD), including 110 deaths, were reported in 30 European Union/European Economic Area Member States.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
The downloadable data file contains the data on which the maps requested in the Council Recommendation on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic in EU/EEA and the UK are based. They are published every Thursday.
ECDC works together with the institutions and agencies of the EU, in particular the European Commission’s Directorate-General for Health and Food Safety (DG SANTE), the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).